MedTrace Logo

Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors

NCT00278239 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2013-09-20

No results posted yet for this study

Summary

RATIONALE: Questionnaires that measure quality of life may improve the ability to plan treatment for patients with primitive neuroectodermal tumors.

PURPOSE: This phase III trial is studying quality of life in patients who have undergone previous treatment for primitive neuroectodermal tumors.

Conditions

Interventions

PROCEDURE

cognitive assessment

PROCEDURE

psychosocial assessment and care

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • Children's Cancer and Leukaemia Group

    lead OTHER

Principal Investigators

  • Colin Kennedy · University Hospital Southampton NHS Foundation Trust

Eligibility

Min Age
3 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30

Countries

  • Ireland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00278239 on ClinicalTrials.gov